Ancient Slashdot reader jd shares a report from The Guardian: Neuralink's first attempt at implanting its chip in a human being's skull hit an unexpected setback after the device began to detach from the patient's brain, the company revealed on Wednesday. The patient, Noland Arbaugh, underwent surgery in February to attach a Neuralink chip to his brain, but the device's functionality began to decrease within the month after his implant. Some of the device's threads, which connect the miniature computer to the brain, had begun to retract. Neuralink did not disclose why the device partly retracted from Arbaugh's brain, but stated in a blog post that its engineers had refined the implant and restored functionality. The decreased capabilities did not appear to endanger Arbaugh, and he could still use the implant to play a game of chess on a computer using his thoughts, according to the Wall Street Journal, which first broke the news of the issue with the chip. The possibility of removing the implant was considered after the detachment came to light, the Journal reported. [...] Arbaugh praised the implant during a demonstration in March and said that it had "already changed his life," while also stating that it had not been perfect and they "have run into some issues."

Read more of this story at Slashdot.

Nolwenn Leroy : rare photo avec son fils Marin, pour accueillir la flamme à Marseille  Paris MatchVoir la couverture complète sur Google Actualités

Jess Weatherbed reports via The Verge: At least 224 people with diabetes have reported injuries linked to a defective iOS app that caused their insulin pumps to shut down prematurely, according to the US Food and Drug Administration (FDA). On Wednesday, the agency announced that California-based medical device manufacturer Tandem Diabetes Care has issued a recall for version 2.7 of the iOS t:connect mobile app, which is used in conjunction with the company's t:slim X2 insulin pump. Specifically, the recall relates to a software issue that can cause the app to repeatedly crash and relaunch, resulting in the pump's battery being drained by excessive Bluetooth communication. This battery drain can cause the pump to shut down "earlier than typically expected" according to Tandem, though the pump will notify users of an imminent shutdown via an alarm and low-power alert. The company has notified customers to update the mobile app to version 2.7.1 or later, which should fix the defective software. While no physical recall is taking place, the FDA has identified this as a "Class I" recall -- the most serious type, as it relates to issues with products that can potentially cause serious injuries or death. No deaths linked to the issues have been reported as of April 15th. Tandem is encouraging pump users to take particular care when they sleep as it's easier to miss battery depletion warnings, and is asking impacted customers to confirm they have been notified of the recall via this online form. For any other questions or concerns about the insulin pump recall, customers should contact Tandem Diabetes Care directly.

Read more of this story at Slashdot.

L’agresseur venait de se faire interpeller, jeudi, et les fonctionnaires procédaient à sa fouille quand il s’est emparé de l’arme de l’un d’eux.

© BERTRAND GUAY / AFP

Eurovision 2024 : voici les 10 favoris, selon les bookmakers  CNEWSVoir la couverture complète sur Google Actualités